Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers
H. Kim Lyerly(Duke University), Thomas G. Gross(Inserm), Greg Reaman(Pharmaceuticals and Medical Devices Agency), Silvy da Rocha Dias(Pharmaceuticals and Medical Devices Agency), Zhimin Yang(Fujian Medical University), Ken Hatogai(Pharmaceuticals and Medical Devices Agency), Daniel T. McManus(Pharmaceuticals and Medical Devices Agency), Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Olufunmilayo I. Olopade(University of Chicago), Renzo Canetta(Pharmaceuticals and Medical Devices Agency), Jun Ren(Wuhan University), Kathy Soltys(Pharmaceuticals and Medical Devices Agency), Nancy Goodman(Pharmaceuticals and Medical Devices Agency), Hiroshi Katayama(National Cancer Center), Gi Hyun Kim(Pharmaceuticals and Medical Devices Agency), Sumimasa Nagai
Cited by 13
Related Papers
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
|Genome biology|2007|1.3k
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
|Nature Genetics|2003|583